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SUMMARY
Expansion of pulmonary neuroendocrine cells (PNECs) is a pathological feature of
many human lung diseases. Human PNECs are inherently difficult to study due to
their rarity (<1%of total lung cells) and a lack of establishedprotocols for their isola-
tion. We used induced pluripotent stem cells (iPSCs) to generate induced PNECs
(iPNECs), which express core PNECmarkers, including ROBO receptors, and secrete
major neuropeptides, recapitulating known functions of primary PNECs. Further-
more, we demonstrate that differentiation efficiency is increased in the presence
of anair-liquid interface and inhibitionofNotch signaling. Single-cell RNAsequencing
(scRNA-seq) revealed a PNEC-associated gene expression profile that is concordant
between iPNECs and human fetal PNECs. In addition, pseudotime analysis of scRNA-
seq results suggests a basal cell origin of human iPNECs. In conclusion, ourmodel has
thepotential to provide an unlimited source of human iPNECs to explore PNECpath-
ophysiology associated with several lung diseases.
INTRODUCTION
Pulmonary neuroendocrine cells (PNECs) are endogenous chemosensory cells that form around gesta-
tional week 8 in humans, making them the first differentiated cell type to appear in fetal lung (Cutz
et al., 1985). Innervated clusters of PNECs in the human airway epithelium are referred to as ‘‘neuro-epithe-
lial bodies or NEBs’’ (Lauweryns and Peuskens, 1972; Lauweryns and Van Ranst, 1988). PNECs are multifunc-
tional cells with known roles in oxygen sensing, redistribution and regulation of blood flow especially
during hypoxia, modulation of immune responses, and stimulation of intraepithelial vagosensory nerve fi-
bers (Linnoila, 2006; Sunday, 1996). In addition, PNECs have been reported to serve as a stem cell niche
during severe lung injury, with the potential to give rise to club and ciliated cells (Ouadah et al., 2019;
Song et al., 2012). PNEC ontogeny, however, is not entirely clear. A recent lineage tracing study in mice
showed that a small population of cells expressing the basal cell marker, tumor protein 63+ (TP63+), and
labeled at embryonic day (E) 9.5, gave rise to calcitonin gene-related polypeptide alpha (CGRP)-expressing
PNECs, that can be detected at E18.5 by immunostaining (Yang et al., 2018). However, whether basal cells
have the capacity to give rise to PNECs in the human fetal or adult lung remains to be determined.
A spectrum of lung disorders including neuroendocrine hyperplasia of infancy (NEHI), chronic obstructive
pulmonary disease (COPD), cystic fibrosis, asthma, bronchopulmonary dysplasia (BPD), and pulmonary hy-
pertension are associated with expansion of PNECs in the airway epithelium (Cutz, 2015; Cutz et al., 2007;
Gu et al., 2014; Johnson et al., 1985; Johnson and Georgieff, 1989; Pan et al., 2006; Schindler et al., 1995).
The pathophysiological consequences of increased PNEC abundance in these diseases is not clear. As
PNECs comprise <1% of all respiratory cell types, primary PNECs are inherently difficult to isolate in suffi-
cient quantities for detailed characterization. We, therefore, addressed an unmet need to develop a model
system for efficiently generating human PNECs to study their physiological and pathological functions us-
ing induced pluripotent stem cells (iPSCs).
Within the lung milieu, activation of pro-neural transcription factor ASCL1 (Achaete-Scute Family BHLH
Transcription Factor 1) is required for cells to form the pulmonary neuroendocrine lineage (Linnoila,
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2006). The Notch-HES1/HEY1 (Hairy/Enhancer-Of-Split related BHLH transcription factor family) pathway
regulates the non-neuroendocrine fate of lung endoderm by repressing pro-neural genes like ASCL1
(Henke et al., 2009; Nelson et al., 2009). Recently, it has been shown that inhibition of Notch can increase
PNEC production (Chen et al., 2019). These studies, however, focused specifically on modeling small cell
lung carcinoma (SCLC) using human embryonic stem cell-derived PNECs, or on generating proximal airway
epithelial spheroids from human pluripotent cells (Chen et al., 2019; Konishi et al., 2016). In-depth charac-
terization of iPNECs or comparison at the transcriptional level with primary PNECs was not performed. In
this article, we report the differentiation of iPSCs to human iPNECs with a gene expression profile similar to
that of primary fetal PNECs that could be used in future studies of pathophysiological changes in diseases
such as NEHI or BPD.
RESULTS
Directed Differentiation of iPSCs to iPNECs
We adapted our previously published differentiation protocol to create airway epithelium from human
iPSCs, recapitulating the key stages of embryonic lung development (Firth et al., 2014). iPSCs were differ-
entiated in culture without sorting, resulting in a mixed population of mesoderm and epithelium
comprising the proximal airways. To validate the presence of PNECs in our directed differentiation, cul-
tures were stained for a panel of genes known to be expressed in primary human PNECs (Linnoila, 2006;
Sunday, 1996), including synaptophysin (SYP), chromogranin A (CHGA), PGP9.5 (expressed by the gene
UCHL1), and neuron-specific enolase (ENO2). After 31 days of differentiation, including culture at an air-
liquid interface (ALI) from Day 17, cells expressing these PNEC markers were observed in cultures gener-
ated from three independent iPSC lines (Figures 1A and S1A). Expression of SYP, CHGA, PGP9.5, and
ENO2 was quantified as a percentage of the mean fluorescence intensity (MFI) of the respective marker
normalized to the expression of nuclear marker 40,6-diamidino-2-phenylindole (DAPI). The distribution of
these markers ranged from 31.64% G 3.01% MFI for SYP to 61.20% G 4.78% MFI for ENO2 (Figure 1B).
Orthogonal projection of the differentiated cultures revealed that iPNECs are present in closer proximity
to the apical-air interface (Figure S1B). Analysis of key PNECmarkers, including ENO2 and SYP, throughout
the differentiation time course from iPSC indicated that ENO2 protein was robustly expressed from Day 13
(Figure S2A), whereas SYP expression was increased gradually after exposure at the ALI, from Day 17 on-
ward. (Figure S2B). Expression of these PNECmarkers was additionally validated in explanted human adult
lung tissue sections (Figure 1C). Cells expressing SYP, CHGA, and PGP9.5 were identified within the epithe-
lium of the distal airways. In support of observations in our iPNEC cultures, ENO2 expression was also more
widespread than the other PNEC markers in the human lung sections (Figure 1C), consistent with ENO2
being expressed in other lung cells in addition to PNECs. Indeed, our data indicated that KRT5+ basal cells
co-express ENO2 in adult human lung tissues (Figure S2C). This is also supported by data deposited in the
LungMAP database (www.lungmap.net). Gastrin-releasing protein (GRP), also known as bombesin, is
another key marker of PNECs whose expression peaks during human fetal lung development around
week 20–23 (Linnoila, 2006; Sunday, 1996; Sunday et al., 1991). GRP mRNA expression peaked during spec-
ification of the primordial lung progenitor cells from ventralized anterior foregut endoderm, Days 13–17 of
our iPSC differentiation protocol (Figure S2D), and then decreased.
Induction of PNECs Is Augmented by Air-Liquid Interface Culture during Directed
Differentiation
Based on our observations that SYP expression increased after exposure of the differentiation cultures to
an ALI, we evaluated whether the air interface was an important factor in PNEC induction.We continued the
culture of primordial lung progenitors at Day 17 of differentiation (Firth et al., 2014), in both submerged and
ALI conditions. Owing to consistency in staining across experimental replicates, the relative MFI of SYP:-
DAPI was compared (Figure 1B). After 14 additional days of differentiation through to experimental Day
31, SYP+ iPNECs were only detected in the presence of an ALI (Figure 1D, bottom panel). No SYP-express-
ing cells were observed in continually submerged cultures (Figure 1D, top panel), indicating that air expo-
sure provides a microenvironment suited to the continued development of PNECs.
Characterization of Human iPNECs
To comprehensively characterize and validate iPNECs, we co-labeled the differentiating cultures with
NKX2.1, a primordial lung endoderm transcription factor; EPCAM, a pan-epithelial marker; and vimentin,
VIM, a mesenchymal marker, in combination with the PNEC marker SYP. SYP+ iPNECs co-express NKX2.1
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supporting a lung endodermal origin, but do not express VIM or EPCAM (Figures 2A and 2B). Human lung
tissue sections were used to validate this co-staining pattern: primary PNECs within these sections also co--
express NKX2.1, but not EPCAM or VIM, supporting our iPNEC data (Figure 2B). NKX2.1 also identifies
neuronal cells developing in the forebrain (Germain et al., 2013; Goulburn et al., 2011); therefore, to
exclude the possibility that our differentiation was creating forebrain neurons we stained for additional
neuronal-specific marker, microtubule-associated protein 2 (MAP2), at Days 31 and 60 of differentiation.
No MAP2 expression was evident at either of these time points (data not shown).
Figure 1. Directed Differentiation of Human iPSCs into iPNECs
(A) Representative immunofluorescence (IF) images of iPNECs at Day 31 of differentiation at the ALI show expression of
SYP, CHGA, PGP9.5, and ENO2 (all red). Left panels (203) represent low-power images (scale bars, 50 mm), and right
panels (403) show magnified views (scale bars, 10 mm).
(B) Quantification of PNEC marker expression at Day 31 of differentiation expressed as percentage MFI of each marker in
relation to total DAPI fluorescence. Data are expressed as mean G SEM from 3 independent experiments.
(C) Representative IF images of primary PNECs in adult human distal lung show expression of SYP, CHGA, PGP9.5, and
ENO2 (all red). Yellow dotted lines demarcate the airways. Left panels (203) represent low-power images (scale bars,
100 mm), and right panels (403) show magnified views of the marked areas (scale bars, 50 mm).
(D) Representative IF images of iPNECs in submerged and ALI cultures stained for SYP (green). Scale bars, 200 mm. Nuclei
are counterstained with DAPI (blue).
See also, Figures S1 and S2.
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NOTCH Inhibition Augments iPNEC Specification and Phenotypic Complexity
A transcriptional program regulated by transcription factor ASCL1 is required for activating the neuroen-
docrine lineage in developing lung to generate PNECs (Linnoila, 2006). ASCL1 expression is known to be
repressed by NOTCH signaling, which supports expansion and differentiation of lung basal and secretory
cells, respectively. During iPSC differentiation, ASCL1 mRNA is detectable from Day 10 (Figure S2E), pre-
ceding the appearance of SYP+ cells from Day 13 (Figure S2B). We also observe that expression of HEY1/
HES1, downstream targets of the NOTCH pathway, peaks between Days 10 and 17 of differentiation
(Figures S2F and S2G), whereas ASCL1 peaks at Day 31 (Figure S2E). This suggests that in our differentia-
tion protocol, much like during development, there is an inverse correlation between activity of the Notch
signaling pathway and ASCL1 expression. To evaluate the impact of Notch inhibition on neuroendocrine
differentiation and expansion during our differentiation protocol, we performed a dose-response to
Figure 2. Characterization of Human iPNECs
(A) Representative immunofluorescence (IF) images of ALI cultures at Day 31 of directed differentiation: SYP+ iPNECs
(red), NKX2.1, EPCAM, and vimentin (VIM) (all green). Left panels (203) represent low-power images (scale bars, 200 mm),
and right panels (403) show magnified views of the marked areas (scale bars, 10 mm).
(B) Representative IF images of adult human distal lung sections: SYP+ iPNECs (green), NKX2.1, EPCAM, and VIM (all red).
Yellow dotted lines demarcate the airways. Left panels (20X) represent low-power images, and right panels (403) show
magnified views of the marked areas (scale bars, 50 mm). Nuclei are counterstained with DAPI (blue).
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g-secretase/Notch inhibitor, 3tert-Butyl(2S)-2-[[(2S)-2-[[2-(3,5-difluorophenyl) acetyl] amino] propanoyl]
amino]-2-phenylacetate (DAPT). As before, marker expression was quantified as a percentage of the MFI
for the respective marker normalized to the MFI of nuclear marker DAPI. Continuous addition of 1, 10,
and 20 mM DAPT to cultures from Day 17 onward resulted in a dose-dependent increase in the relative
MFI of SYP at Day 31 (Figures S3A, 3A, and 3B). The effect of Notch inhibition was validated using a second
Notch signaling inhibitor, dibenzazepine (DBZ), at 0.5, 2, and 5 mM. A 2-fold increase in relative MFI of SYP
was observed when increasing the concentration of DBZ from 0.5 to 2 mM (Figures 3C and S3B). However,
no further increase in the MFI ratio of SYP was observed with an increase to 5 mM DBZ treatment. These
findings support inhibition of Notch signaling as an important mechanism for augmenting PNEC differen-
tiation and expansion. To deduce the optimal concentrations of Notch inhibitors, DAPT and DBZ, required
for iPNEC differentiation, we also co-labeled Day 31 cultures with cleaved caspase 3, an apoptotic marker
to evaluate whether high concentrations of Notch inhibitors induced toxicity and cell death. Based on
immunofluorescent staining, an increase in the caspase 3+ relative MFI percentage was observed at the
highest concentration (20 mM DAPT and 5 mM DBZ) of the Notch inhibitors (Figures S3A and S3B), indi-
cating that 10 mM DAPT or 2 mM DBZ were optimal for induction of iPNECs. These concentrations were
used for all subsequent experiments. Extended culture of iPNECs with continuous addition of DAPT/
DBZ for up to 90 days resulted in a significant increase in mRNA expression for representative PNEC genes
ASCL1, DLL3, GAD1/GAD67, ENO2, ROBO2, and SYP (Figure 3D). In addition, there was a significant in-
crease in SYP, ROBO2, and CHGA staining (Figures 3E, 3F, and 3H). ENO2 was robustly expressed by
Day 31 with no further increase at Day 91 (Figure 3G). These data support a role for continuous repression
of Notch signaling in augmenting iPNEC expansion and homeostasis. Interestingly, SYP, ROBO2, and
ENO2 staining patterns show an intricate arborized network formation over time in culture. Using Sholl
analysis (Figure S4A), we quantified this arborization as a change in the number of intersections (Figures
S4B, S4D, and S4F) and branching density (Figures S4C, S4E, and S4G) of SYP+, ROBO2+, and ENO2+ iP-
NECs (Binley et al., 2014; Bird and Cuntz, 2019; Sholl, 1953; Stanko and Fenton, 2017; Ferreira et al., 2014).
Such changes in the cellular complexity of the iPNECs likely reflect phenotypic maturation similar to that
observed in the NEBs of adult lungs (Pan et al., 2004, 2006).
Transcriptomic Characterization of iPNECs
To evaluate the transcriptomic profile of iPNECs, we performed single-cell RNA sequencing (scRNA-seq) of cul-
turesmaintainedwith continuous treatment with 10 mMDAPT at Day 91 of iPSCdifferentiation (for schematic see
Figure S5A). Two independent biological replicates were sequenced and analyzed. Based on the quality param-
eters as detailed in Transparent Methods, we selected a set of 1,705 and 1,502 cells from replicates 1 and 2,
respectively, for analysis. The two replicates were corrected for any batch effect before further analysis. A subset
of 1,171 most variable genes that showed a high level of concordance between the two replicates was selected
for further downstream analysis (Pearson correlation coefficient, r = 0.94, Figure S5B). A flowchart describing the
bioinformatics analysis pipeline for the scRNA-seq data is shown in Figure S5C. Unsupervised graph-based clus-
tering (false discovery rate, FDR p < 0.05) and non-linear dimensionality reduction distributes the cells into six
independent cell populations on Day 91 of differentiation (Figure 4A). Two of these clusters, labeled iPNEC1
and iPNEC2, representing >30% of the cells captured, were defined by a transcriptomic signature to reflect a
neuroendocrine lineage determined by the expression of known PNEC genes including, but not limited to,
SYP, CHGA, PGP9.5, ENO2, and ROBO2. Further in-depth analysis revealed that these two clusters are sepa-
rated from the other cell clusters by differential expression (fold change, FC) of key PNEC marker genes SYP,
ENO2, UCHL1, and CHGA, and Notch pathway genes, HES1 and NOTCH2 (Figure 4B). The larger cluster, iP-
NEC1 (yellow dots), has a higher degree of Notch repression and a higher FC of SYP, ENO2, UCHL1, and
CHGA than the smaller cluster, iPNEC2 (blue dots). For all subsequent analyses the two clusters, iPNEC1 and
iPNEC2 were grouped together as iPNECs. A set of 255 differentially enriched genes (FDR p < 0.05; FC R
1.5) was identified using gene set enrichment analysis against a compendium of 350 different human tissues
and cell types; we refer to this set of genes as iPNEC-associated genes. Figure S5C shows a flowchart describing
the process of identifying 255 iPNEC-associated genes. In a genome-wide comparison, these 255 genes are
significantly enriched (FDR p < 0.5, FCR 1.5) in the putative iPNEC cell population compared with other pop-
ulations (Figure 4C) and includesestablishedPNECmarkergenes includingSYP,CHGA, andROBO2 (Figure 4D).
UCHL1, although highly enriched within the iPNEC cluster, is also expressed in the non-iPNEC population. Ac-
cording to the LungMAP database, UCHL1 is also expressed to some extent by lung mesenchyme (www.
lungmap.net). We observed co-differentiation of mesenchymal-like clusters in our Day 91 cultures (VIM+ fibro-
blast-like and ACTA2+ smooth muscle cells in Figure 4A), which could contribute to UCHL1 expression within
the non-iPNEC population. PNECs receive stimulation from neurotransmitters/neurosecretions innervating
ll
OPEN ACCESS
iScience 23, 101083, May 22, 2020 5
iScience
Article
the lung and respond to such stimuli by releasing hormones (neuropeptides and amines). PNECs, therefore,
have important functions in assimilating characteristics of both the nervous and endocrine systems. Accordingly,
analysis of the pathways most enriched in the 255 gene set includes neuronal system development, synaptic
Figure 3. Extended Notch Inhibition Increases iPNEC Specification and Phenotypic Complexity
(A–C) (A) Representative immunofluorescence (IF) images and quantification of SYP+ iPNECs (red) at Day 31 of
differentiation in the presence of DAPT (1 mM and 10 mM). Quantification of SYP expression (MFI expressed as a
percentage of total DAPI fluorescence) at Day 31 of differentiation in the presence of (B) DAPT (1 mM and 10 mM) (paired t
test) and (C) DBZ (0.5 mM, 2 mM and 5 mM) (one-way ANOVA). Data are expressed as mean G SEM from 3 independent
experiments. **p < 0.01, ****p < 0.0001.
(D–L) (D) Quantitative RT-PCR showing PNEC marker expression after 91 days of differentiation. Data are normalized to
internal control b-actin and expressed as comparisons among Days 31, 60, and 91 with respect to Day 0. N = 3
experimental replicates each with 3 technical replicates. One-way ANOVA. *p < 0.05, **p < 0.01, ****p < 0.0001. MFI
expressed as percentage of DAPI fluorescence for cells expressing SYP+ (E), ROBO2+ (F), ENO2+ (G), and CHGA+ (H) at
Days 31, 60, and 91 of differentiation. One-way ANOVA. **p < 0.01, ****p < 0.0001. Scale bars, 100 mm. Nuclei are
counterstained with DAPI (blue). (E) Representative IF images show SYP+ (I), ROBO2+ (J), ENO2+ (K), and CHGA+ (L) cells
at Days 31, 60, and 91 of differentiation (all red).
See also Figures S3 and S4.
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Figure 4. Transcriptomic Characterization of iPNECs
(A) tSNE plot identifies six cell clusters in two replicates of 91-day old iPSC differentiated cells.
(B) Expression of representative genes between iPNECs1 and iPNECs2. Fold change represents differential expression
between iPNEC1/2 clusters versus other cells.
(C) Box whisker plot comparing 255 iPNEC-associated genes within iPNEC and non-iPNEC populations. Key PNEC
markers are shown (CHGA, SYP, UCHL1, ENO2, and NEUROD1).
(D) Violin plots showing expression of individual PNECmarker genes (ROBO2, CHGA, SYP, and UCHL1) within iPNEC and
non-iPNEC populations.
(E) Signaling pathways altered within 255 iPNEC-associated genes.
(F) Scatterplot showing concordance of expression of 151 common genes (Pearson correlation coefficient, r = 0.75) in Day
91 iPNECs and human fetal lung-derived primary PNECs pooled from gestational weeks 15, 18, and 21.
(G) Heatmap comparing the gene expression signature between iPNECs and human fetal lung-derived primary PNECs
pooled from gestational weeks 15, 18, and 21.
(H) Venn diagram showing the number of genes overlapping between iPNECs and human fetal lung-derived primary
PNECs and the known key PNEC markers that are common between the two samples.
See also Figures S5 and S6.
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vesicle biogenesis, and bioactive peptide signaling (Figure 4E), consistent with some of the known functions of
PNECs. We also observe Notch signaling as one of the most differentially altered pathways (Figure 4G), reflect-
ing the fact that continued Notch inhibition was administered to induce a neuroendocrine fate.
Given the limited number of PNECs in human lung, performing RNA sequencing on primary PNECs is chal-
lenging. We, therefore, procured the only available scRNA-seq dataset of human fetal lung explants
pooled from gestational weeks 15, 18, and 21 (EMBL-EBI ArrayExpress Database: E-MTAB-8221) (Miller
et al., 2018) and compared the neuroendocrine cluster (220 cells) with the iPNEC cluster within our
scRNA-seq dataset (GEO accession number: GSE146990). Comparative analysis revealed a significant cor-
relation coefficient (r = 0.75) with a high concordance of 151 genes found to be commonly expressed be-
tween iPNECs and fetal PNECs (Figure 4F). One-way hierarchical clustering indicates an overall similar
gene expression pattern between iPNECs and human primary fetal PNECs (Figure 4G) including expres-
sion of all known major PNEC genes such as SYP, CHGA, PGP9.5, ROBO2, ASCL1, NCAM1, ENO2,
DLL3, and NEUROD1 (Figure 4H and Tables S1, S2, and S3), indicating considerable overlap between
the transcriptomes of iPNECs and primary human fetal PNECs.
PNECs are considered neuroepithelial in nature; however, we did not observe co-staining of iPNECs or pri-
mary PNECs in human lung tissue sections stained with epithelial marker EPCAM (Figures 2A and 2B). To
further clarify the whether EPCAM is expressed in PNEC we further analyzed the scRNA-seq data. In fetal
PNECs, Miller et al., identified a neuroendocrine cell population within a computationally extracted epithe-
lial cluster based on high EPCAM expression (Miller et al., 2018). Detailed analysis of the human fetal lung
scRNA-seq data enabled a differentiation of two subsets of fetal PNECs based on EPCAM expression: of
the 220 fetal PNECs 77 were EPCAM+ and 143 EPCAM. Analysis of our 255 PNEC-associated genes in
EPCAM fetal PNECs indicated a significant concordance of 243 genes between both datasets (read count
R2, r = 0.6) (Figure S5D). We, therefore, demonstrate that (1) a majority of human fetal PNECs do not ex-
press EPCAM and (2) iPNECs have significant gene expression concordance with human fetal PNECs.
iPNECs Express and Secrete Major Neuropeptides
PNECs contain vesicles filled with neuropeptides, amines, and neurotransmitters that are secreted upon
stimulation. Recently, neuropeptides proenkephalin (PENK), somatostatin (SST), and neurotransmitter syn-
aptic vesicle protein 2 (SV2) have been shown to be secreted by primary PNECs (Branchfield et al., 2016).
Differentiation cultures at days 31, 60, and 91 containing greater than 30% iPNECs (Figures 3 and 4) express
PENK, SST, and SV2 at the mRNA level (Figure 5A). ENO2 secretion has been widely used as a biochemical
marker to monitor the progression of PNEC-associated disorders, namely SCLC and pulmonary neuroen-
docrine tumors (Anastasiades et al., 1987; Kasprzak et al., 2007). Immunostaining of our cultures at Day 91
confirms that the majority of SYP+ cells co-express ENO2 (Figure S6B). We, therefore, proceeded to
Figure 5. Neuropeptide and Marker Expression Profile of iPNECs
(A) qRT-PCR showing the neuropeptide profile of cultures at Day 0, 31, 60, and 91 of differentiation. Data are normalized
to internal control b-actin and expressed as comparisons among Days 31, 60, and 91 with respect to Day 0. N = 3
experimental replicates each with 3 technical replicates. One-way ANOVA. *p < 0.05, ****p < 0.0001.
(B) Enzyme-linked immunosorbent assay (ELISA) data showing secreted levels of enzyme ENO2 in the culture media. N = 4
experimental replicates. One-way ANOVA, ****p < 0.0001.
See also Figure S6.
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perform an ELISA to evaluate whether SYP+ iPNECs also secrete ENO2. Media were collected from the ba-
solateral compartment of Day 91 ALI cultures used for the scRNA-seq experiment using basal media and
iPSC-conditioned media as negative controls and recombinant ENO2 as a positive control. Day 91 differ-
entiation cultures, containing >30% iPNECs (Figures 3 and 4), expressed ENO2 at mRNA (Figures 3D and
S6A) and protein levels (Figure 5B) in the absence of external stimulation, showing similarity in terms of their
gene expression profile to primary PNECs as previously shown (Cutz et al., 2008). It is important to note that
scRNA-seq analysis indicates that ENO2 expression is only found in the defined iPNEC populations (Fig-
ure S6A) supporting selective release of ENO2 from iPNEC in our Day 91 cultures.
Human Basal Cells Are Capable of Differentiating into PNECs
Lineage tracing studies inmice have indicated that TP63+ basal cells can give rise toPNECs (Yanget al., 2018). To
determine whether human basal cells are also able to differentiate into PNECs, we performed two experiments:
(1) pseudotime analysis of our human differentiation Day 91 iPNEC scRNA-seq data and (2) ALI differentiation of
purified human tracheal epithelial cells (HTECs). We analyzed the scRNA-seq data of Day 91 differentiation cul-
tures to track cell population changes across the differentiation trajectory (Figure 4). A stream plot was gener-
ated using Stream and Monocle3 for easy visualization of the different cell types in our cultures projected
onto the differentiation trajectory ‘‘tree’’ according to their pseudotime locations and the distances from their
assigned branches (Figure 6A). Based on the cell state during the reprograming each cell type/population is as-
signed to a distinct ‘‘branch’’ of the ‘‘tree’’ representing a specific cell fate choice/developmental lineage that
proceeds down a distinct path. Cells on the same or nearby branches are predicted to be hierarchically related.
The stream plot (Figure 6A) indicates that several different cell types are present in our Day 91 differentiation
cultures including basal cells, respiratory smoothmuscle-like cells, fibroblast-like cells, and iPNECs. We demon-
strate that the key genes expressed in the S3 – S0 branch overlapwith the published human lung basal cell data-
base (GSE24337), confirming that iBasal cells in this culture possess a transcriptomic signature resembling that or
primary human basal cells (Figure 6B). We tracked six key PNEC marker genes, INSM1, UCHL1, NCAM1, SYP,
NEUROD1, and ENO2 across the branches where a significant increase in their expression was detected as
the cells transition from the iBasal cell state into the two iPNEC trajectories S0 – S1 or S0 – S2 (p < 0.001, Figures
S7A–S7F). To further confirm the differentiation of iBasal cells to iPNECs, we used the reverse graph embedding
tool in Moncole3 to reconstruct an unbiased lineage trajectory and assigned iBasal cells as the starting cell line-
age (Figure 6C). Cells start at the root (State 1) and progress to one of the two alternative reprogramming out-
comes, denoted by State 2 or State 3. Monocole3 trajectories support that iBasal cells differentiate into two
states, State 2 and State 3, which correspond to the two different states of iPNECs, iPNEC1 and iPNEC2 respec-
tively. Therefore, it is possible that the two populations observed in graph-based clustering in Figure 4A repre-
sent two different physiological states of iPNECs, as observed by Monocle3 (Trapnell, 2020; Trapnell et al.,
2014a, 2014b). Analysis of the differentially expressed genes between State 2 (iPNEC1) and State 3 (iPNEC2) in-
dicates a difference in the level of the PNEC marker gene expression. UCHL1, NCAM1, and INSM1 are high in
iPNEC1, whereas SYP and ENO2 are high in iPNEC2 (Figure 6D). Overall, the pseudotime trajectory analysis sup-
ports an iBasal cell predating iPNECs in the differentiation protocol described in this article. Purification and
expansion of iPSC-derived basal cells is currently challenging. We therefore used HTECs to corroborate our
in silico finding. HTECs, consisting almost exclusively of a self-renewing population of KRT5+/TP63+ basal cells
(Figure S8A), were cultured at the ALI and stained for SYP. After more than 75 days of differentiation at the ALI,
the distribution of SYP staining in the cultures was estimated to be 17.71%G 2.49% based on the relative MFI
percentage of SYP:DAPI (Figures 6E, 6F, and S8B). Using two independent approaches our data strongly sug-
gest that human basal cells, both iPSC-derived and primary, are capable of giving rise to PNECs.
DISCUSSION
We have established a directed differentiation strategy for deriving iPNECs from human iPSCs that are
transcriptomically similar to human fetal primary PNECs. Generation of these cells from a renewable and
patient-specific cellular source overcomes limitations with regard to accessibility to sufficient primary hu-
man PNECs and enhances our capacity to model human diseases, like NEHI. Recent reports have demon-
strated the generation of PNEC-like cells from human pluripotent stem cells; these studies, however,
focused primarily on their sporadic presence in spheroid cultures or on their potential as lung cancer
models (Chen et al., 2019; Konishi et al., 2016) (17, 18). To date, there has been no in-depth phenotypic
and transcriptional characterization of these cells to validate their similarity to their primary counterparts.
The iPNEC differentiation protocol described in this article is adapted from our previously established
airway epithelial differentiation protocol to specifically promote differentiation toward the neuroendocrine
lineage (Firth et al., 2014). Using this model we are able to generate iPNECs expressing all major PNEC
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marker genes including SYP, CHGA, PGP9.5, ROBO2, and ENO2, consistent with primary human and ro-
dent PNECs (Branchfield et al., 2016; Linnoila, 2006; Sunday, 1996). By specifically adapting the culture con-
ditions to favor expansion of PNECs we are able to generate cultures with an increased efficiency of gener-
ating iPNECs over currently published protocols (Chen et al., 2019). Our differentiation is robust across
Figure 6. Human Basal Cells Differentiate into PNECs
(A) Stream plot of scRNA-seq data showing lineage differentiation trajectories of iPSC-derived Day 91 cultures. Cells are
assigned a distinct color based on cell types. Cells on the same branch are predicted to be hierarchically related.
(B) Z-score of highly enriched genes across S3 – S0 trajectory that overlaps with human lung basal cell microarray dataset
GSE24337). Relative gene expression level across each trajectory was calculated as a Z-score of log2 (CPM+1) where CPM
denotes counts per million. A positive Z-score indicates a score that is higher than the mean.
(C) Monocle-based lineage reconstruction of pseudotemporal trajectories superimposing both cell fate and cell states
during differentiation from iBasal cells to iPNECs. Cells can differentiate from State1 (iBasal cells) to State 2 (iPNEC1) or
State 3 (iPNEC2).
(D) Z score of highly enriched genes across trajectories S0 – S1 and S0 – S2 corresponding to two states of iPNECs, iPNEC1
and iPNEC2 respectively.
(E) Representative immunofluorescence images showing SYP+ PNECs (red) in >78 days ALI cultures from primary HTEC.
Scale bars, 25 mm.
(F) Quantification of SYP+ PNECs in HTEC cultures expressed as MFI percentage of SYP fluorescence relative to total DAPI
fluorescence.
Data are expressed as mean G SEM. N = 7 experimental replicates. See also Figures S7 and S8.
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multiple iPSC lines despite inherent variability between stem cells lines/clones with regard to their differ-
entiation efficiency. Furthermore, differentiation protocols, such as those developed in this study, rely on
the sequential application of growth factors and cytokines directing differentiation toward lung epithelium:
at any given point cells may be captured at varied stages of differentiation and maturation, again contrib-
uting to heterogeneity. It should be noted that our iPNEC protocol does not utilize any purification steps
and thus an endpoint culture composed of mesenchymal (niche) cells and epithelium is generated with the
iPNECs. Isolation of iPSC-derived lung basal cells, akin to primary HTEC, and differentiation toward PNECs
may reduce this variability; however, loss of putative niche cells may also impact efficiency. Such factors will
be evaluated in a subsequent study (Ryan laboratory, unpublished data).
Interestingly, we found that exposure to an air interface was important for the continued development of iP-
NECs. This condition typically mimics the microenvironment of the postnatal and adult lung (Van Haute et al.,
2009; Wong et al., 2015, 2012; Yamaya et al., 1992). This observation has not previously been reported, and
although PNECs first appear in the embryonic lung when the lung is filled with amniotic fluid (Hooper and Har-
ding, 1995;Morrisey andHogan, 2010), it is in the adult lung, when the lung is exposed to air/oxygen, that PNECs
are known to function as airway chemosensors (Garg et al., 2019; Linnoila, 2006; Nikolic et al., 2018; Sunday,
1996). Our protocol mimics this trajectory, with iPNECs being detected for the first time around Day 13 of differ-
entiation, correlating with the early specification of NKX2.1-expressing anterior foregut endoderm cells (Fig-
ure S1B); at this stage the cultures are still submerged. Persistent culture in submerged growth conditions after
specification of the primordial lung progenitor results in complete loss of the SYP-expressing cells suggesting
that this microenvironment is not conducive to their continued growth and proliferation. There are a number
of factors that may influence this including exposure to a more hypoxic environment upregulating hypoxia
response genes such as HIF-1a and HIF-2a causing an upregulation of Notch signaling, as previously reported
(Gerovac et al., 2014). Notch upregulation, in turn, is known to be antagonistic toward PNEC fate induction (Yao
et al., 2018). Existing literature has not specifically indicated a requirement for an ALI during differentiation to
generate PNEC-like cells (Chen et al., 2019; Konishi et al., 2016). Other iPSC-derived PNECs have been gener-
ated in submerged cultures by formation of spheroids/organoids perhaps accounting for differences in iPNEC
yield observed between these protocols and our current protocol. The continued and strong suppression of
Notch signaling favors PNEC specification in our protocol. We did not observe significant numbers of ciliated
cells under these conditions in contrast to our original protocol.We speculate that thismay bedue to continuous
and increased (10-fold higher) levels of Notch suppression. These cultureswere observed for over 3months, and
a substantial increase in both the number and the phenotypic complexity of iPNECs was evident. Although it is
currently not possible to determine the precise maturity of iPNECs due to a lack of adult human isolated PNECs
for direct comparison, our data suggest that the increase in branched network formation in iPNECs may corre-
late with their cellular maturation over time.
PNECs are considered neuroepithelial in nature (Cutz et al., 2013; Verckist et al., 2017) as they arise from the
undifferentiated epithelial progenitors located at the Id2+ (inhibitor of DNA binding 2) distal tips of the
branching epithelium along with all other epithelial cell lineages within the lung (Rawlins et al., 2009;
Song et al., 2012). However, neither primary nor induced SYP+ PNECs were observed to co-express the
epithelial marker, EPCAM. This finding is in contrast to a recent study inmouse (Montoro et al., 2018), where
analysis of scRNA-seq on purified EPCAM+ tracheal epithelial cells identified a specific cell cluster as neuro-
endocrine. It should be noted that no analysis of EPCAM-negative cells was performed. There are also no
published studies that show co-staining of human PNECs with EPCAM. Furthermore, we found that 65% of
human fetal PNECs analyzed in the dataset from Miller et al. is EPCAM and shows a high level of gene
expression concordance with our iPNECs (Miller et al., 2018). Interestingly, we did not observe CGRP
expression in our iPNECs. CGRP is often used as a PNEC marker; however, its expression and distribution
in PNECs appears to vary among species. CGRP expression in humans, for example, has been observed to
correlate to a cancer phenotype (Edbrooke et al., 1985) and observed to only be present in20% of primary
lung PNECs (Weichselbaum et al., 2005). In human lungs, bombesin/GRP is more robust and widely
accepted as a marker of fetal-stage PNECs (Linnoila, 2006; Sunday, 1996; Sunday et al., 1991). Consistent
with the literature, we also observe GRP expression peaking during the earlier stages of iPNEC differenti-
ation (Days 13 and 17).
Primary PNECs are known to contain neuropeptides that are stored in dense core vesicles in the cytoplasm
and are secreted in response to external stimuli such as hypoxia, nicotine, or tobacco smoke (Branchfield
et al., 2016; Cutz et al., 2013; Linnoila, 2006). The iPNECs generated in this study exhibit similar secretion of
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ENO2 and expression of neuropeptides. ROBO genes that help form sensory organoid clusters in vivo via a
Slit-ligand-dependent process are also a known feature of mouse PNECs (Branchfield et al., 2016).
Due to a lack of gene expression data focusing on PNECs only a small list of genes is available to define and
study PNEC. We hypothesize that our 255 iPNEC-associated genes could serve as a more comprehensive
gene set for PNECs and acknowledge that it will be important to validate the iPNEC-associated gene
signature in adult human PNECs. Interestingly, our scRNA-seq data indicated two distinct iPNEC clusters
from both the t-distributed Stochastic Neighbor Embedding (tSNE) and stream plot analyses, with addi-
tional analysis of cell trajectory predicting that the two clusters correspond to two individual physiological
states. In a recent publication, rare Notch2+ NEstem and intermediate transit amplifying Hes1+ Notch-active
NE cells that contribute to epithelial repair during lung injury in mice were identified (Ouadah et al., 2019).
Despite maintaining our 90-day iPSC PNEC differentiation in the continued presence of Notch inhibition
we are able to observe two individual iPNEC populations with differential levels of Notch2 and Hes1
expression. We hypothesize that these two distinct subpopulations, iPNEC11 (low Notch) and iPNEC2
(high Notch), may resemble the PNEC heterogeneity observed by Ouadah and colleagues (Ouadah
et al., 2019); however, this will require further validation and development of a similar injury model using
human iPSC-derived PNECs.
In conclusion, we have successfully derived PNECs from human iPSCs that resemble the known phenotype
of human fetal and adult primary PNECs at the cellular and molecular levels. This represents an important
step toward creating human cellular models for investigation of lung diseases characterized by PNEC hy-
perplasia, such as NEHI.
Limitations of the Study
In this study, we undertook the directed differentiation of human iPSCs into PNECs and performed robust
characterization of these iPNECs at the cellular and molecular levels. Although we were able to demon-
strate significant gene expression concordance with human fetal lung PNECs, it will be important to also
make comparisons to the transcriptomes of human adult lung PNECs as these data become available to
determine thematuration state of our iPNECs. With <1% of the cellular composition of the adult lung being
PNECs, it remains challenging to capture sufficient cells to profile. Currently, methods for the specific isola-
tion/enrichment of PNECs do not exist, making such comparisons extremely challenging. Although we
have included experiments that support a functional profile for the iPNECs such as the expression and
secretion of major neuropeptides (Figure 5), additional experiments will be important to further establish
their functional competency. Such experiments might include measurement of neuropeptide release un-
der hypoxic conditions and mechanical stress or in response to allergic stimulants, which would also be
beneficial for disease modeling. Although analysis of our scRNA-seq datasets indicates the presence of
two PNEC populations, in the current article the functional differences between these two populations
were not addressed. In future experiments it would be interesting to determine whether these are two in-
dependent PNEC populations or whether they are cells at different stages along the differentiation trajec-
tory. It also remains unclear whether primary or induced PNECs can be expanded ex vivo. This would
require an extensive series of experiments to optimize both the purification and culture of both PNEC
and iPNECs; however, this would be incredibly valuable to further study the biology of PNECs. Finally,
to definitively confirm a basal cell origin of PNECs, lineage tracing will need to be performed in both pri-
mary HTECs and iPSC-derived cultures requiring the generation of iPSC reporter lines.
METHODS
All methods can be found in the accompanying Transparent Methods supplemental file.
DATA AND CODE AVAILABILITY
We have uploaded and made available our single-cell RNA sequencing data generated from our Day 91
differentiation cultures on Gene Expression Omnibus (GEO) database under accession number:
GSE146990.
SUPPLEMENTAL INFORMATION
Supplemental Information can be found online at https://doi.org/10.1016/j.isci.2020.101083.
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Supplemental Figure Legends 
 
Figure S1. Directed differentiation of additional human iPSC lines into iPNECs related to Figure 1. (A) 
Representative immunofluorescence (IF) images of iPNECs at Day 31 of differentiation derived from two 
additional human iPSC lines show expression of SYP, CHGA, PGP9.5 and ENO2 (all red). Scale bars = 50 µm. 
(B) Orthogonal projection of Day 31 of differentiation showing SYP+ iPNEC (red) are present on the top layer of 
the 3D cultures. Nuclei are counterstained with DAPI (blue). Scale bar = 200 µm. 
 
Figure S2. Expression of key PNEC markers during in vitro differentiation and in adult human lung 
related to Figure 1. Representative IF images of (A) ENO2 (scale bar = 100 µm) and (B) SYP (in red) over 31 
days of iPSC differentiation and (C) adult human bronchial lung sections stained for ENO2 (red) and KRT5 
(green) (scale bar = 50 µm). Nuclei are counterstained with DAPI (blue). Relative mRNA expression of (D) GRP 
(E) ASCL1 (F) HEY1 and (G) HES1 over the time course of differentiation; data are normalized to Day 5 of 
differentiation and internal control β-actin and expressed as mean ± SEM from 3 independent experiments.  
 
Figure S3. Notch inhibition dose response to induce optimal iPNEC differentiation related to Figure 3. 
Representative IF images of SYP+ iPNECs (red) and cleaved Caspase 3 (green) at Day 31 of differentiation. (A) 
In the presence of DAPT (1 µM, 10 µM and 20 µM). N=3 experimental replicates. Scale bars =100 µm. (B) In the 
presence of DBZ (0.5 µM, 2 µM and 5 µM). N=2 experimental replicates. Scale bars = 50 µm.  
 
Figure S4. Extended Notch inhibition increases iPNEC phenotypic complexity related to Figure 3.  (A) 
Depiction of Sholl analysis to quantify arbors in an individual image. Quantification of number of intersections 
and branching density for SYP+ (B, C), ROBO2+ (D, E) and ENO2+ (F, G) cells at Days 31, 60 and 91 of 
differentiation. N=3 experimental replicates. One-way ANOVA. *p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001. 
Scale bars = 100 µm. Nuclei are counterstained with DAPI (blue). 
 
Figure S5. Transcriptomic analysis of Day 91 iPNECs related to Figure 4. (A) Schematic representation of 
iPSCs cultured at ALI with 10 µM DAPT for 91 days that were used for single-cell RNA sequencing. (B) 
Correlation of selected 1171 most variable genes among two replicates (Pearson correlation coefficient, r=0.94). 
(C) Flowchart describing the analytical approach taken to derive an iPNEC-associated gene list comprised of 
255 genes. (D) Scatter plot showing concordance of expression of Day 91 iPNECs with respect to human fetal 
lung-derived primary EpCAM-negative PNECs pooled from gestational weeks 15, 18 and 21.  
 
Figure S6. ENO2 and ROBO2 expression in Day 91 iPNECs related to Figure 3, Figure 4 and Figure 5. (A) 
t-SNE plot showing expression of ENO2 among single cells at Day 91 of iPSC differentiation cultures. 
Representative IF images showing (B) ENO2 (red) co-localization with SYP (green) and (C) ROBO2 (red) co-
localization with SYP (yellow) in Day 91 iPSC differentiation cultures. Scale bars = 100 µm. Nuclei are 
counterstained with DAPI (blue).  
 
Figure S7. PNEC marker gene expression in a lineage-specific manner across the trajectories related to 
Figure 6. (A) INSM1 (B) UCHL1 (C) NCAM1 (D) SYP (E) NEUROD1 (F) ENO2. 
 
Figure S8. Human tracheal epithelial basal cells give rise to PNECs related to Figure 6. (A) Representative 
IF images indicate that human adult tracheal epithelium-derived primary (HTEC) cultures are comprised of TP63+ 
and KRT5+ basal cells. Scale bars = 200µm. (B) Representative IF images indicating SYP+ PNECs (red) in >78 
day ALI cultures from human adult tracheal epithelium-derived primary basal cells (HTEC) from 3 individual 

































Supplemental Tables:  
Table S4. Primary antibodies related to Figures 1, 2, 3, 4 and Supplemental Figures S1, S2, S3, S4, S6 
and S8. 
Name Brand Catalog number Dilutions  
SYP Abcam ab32127 1:300 
SYP Santa Cruz Biotechnology sc-17750: SYP (D-4) 1:100 
ENO2 Santa Cruz Biotechnology sc-271384: Enolase (A-5) 1:100 
CHGA Proteintech 60135-1-Ig 1:100 
ROBO2 R&D Systems AF3147 1:100 
PGP9.5 Santa Cruz Biotechnology sc-271639: UCH-L1 (C-4) 1:100 
EPCAM R&D Systems AF960 1:100 
VIM Sigma-Aldrich V6630 1:100 
NKX2.1 Abcam ab76013 1:100 
KRT5 Biolegend 905901 1:100 
TP63 Cell Signaling Technology 4892S 1:100 
 
  
Table S5. Quantitative RT-PCR primers related to Figure 5 and Supplemental Figure S2. 
Gene Forward Reverse 
β-Actin 5’-CATGTACGTTGGTATCGAGGC-3’ 5’-CTCCTTAATGTCACGCACGAT-3’  
HES1 5’-ACGTGCGAGGGCGTTAATAC-3’ 5’-GGGGTAGGTCATGGCATTGA-3’ 
HEY1 5’-AGAGTGCGGACGAGAATGGAAACT-3’ 5’-CGTCGGCGCTTCTCAATTATTCCT-3’ 
ASCL1 5’-CCCAAGCAAGTCAAGCGACA-3’ 5’-AAGCCGCTGAAGTTGAGCC-3’ 
GRP 5’-AAAGAGCACAGGGGAGTCTTC-3’ 5’-TCCTTTGCTTCTATGAGACCCA-3’ 
DLL3 5’-CGTCCGTAGATTGGAATCGCC-3’ 5’-TCCCGAGCGTAGATGGAAGG-3’ 
GAD67 5’-GCTTCCGGCTAAGAACGGT-3’ 5’-TTGCGGACATAGTTGAGGAGT-3’ 
ENO2 5’-CTGATGCTGGAGTTGGATGG-3’ 5’-CCATTGATCACGTTGAAGGC-3’ 
ROBO2 5’-GTTTGTGTTGCGAGGAACTATCT-3’ 5’-GTTTTGTCGGAAGTCATCTCGTA-3’ 




iPSC reprogramming: Human fibroblasts were reprogrammed into iPSCs using lentiviral encoded human 
reprogramming factors (Oct4, Lin28, cMyc, Klf4, Sox2) along with an shRNA targeting human p53 (Firth et al., 
2014). Briefly, 1x 105 cells were transduced with recombinant viral particles for 24-48 hours and plated on feeder 
cells. Twenty-four hours later the media was changed to iPSC media (KO DMEM, 20% KO serum replacement, 
0.01mM β Mercaptoethanol, 1% NEAA, 1% Glutamax (all Invitrogen) and 10 ng/ml FGF-2) and subsequently 
replaced every other day. For titer calculation, 293T cells were transduced by different reprogramming viruses 
for 2 days and percent of transduced cells was determined by staining for OCT4. Colonies displaying good stem 
cell morphology were individually picked and expanded, usually around day 15-21. Two additional human 
lymphoblastoid cell lines from healthy subjects (ND00184 and ND03719) were obtained from the National 
Institute of Neurological Disorders and Stroke (NINDS) Biorepository at the Coriell Institute. These lines were 
reprogrammed into iPSCs and served as biological replicates (labeled ‘iPSC1’ and ‘iPSC2’ respectively in Fig. 
S1A). These lines were created using episomal plasmids, encoding 5 factors POU5F1, SOX2, KLF4, MYCL, and 
LIN28A and an shRNA to p53 (Okita et al., 2013) and maintained on Geltrex (Life Technologies) or Matrigel (BD 
Bioscience) in mTeSR1 medium (STEMCELL Technologies) supplemented with penicillin/streptomycin. 
 
Differentiation to airway epithelium: Transwell inserts were coated with a combination of fibronectin (5 μg/mL; 
BD Biosciences), laminin (5 μg/mL; Sigma-Aldrich), and collagen IV (60 μg/mL; Sigma-Aldrich), or six-well plates 
were coated with Geltrex at a 1:200 dilution from a 15 mg/ml stock (Thermo Fisher Scientific, A1413302). iPSCs 
were dissociated to a single-cell suspension using Accutase (Stemcell Technologies, 7920). Then, 300,000 
iPSCs were plated per 30-mm insert or 120,000 per 12-mm insert in mTeSR (Stemcell Technologies, 85850) 
with 10 μM ROCK inhibitor Y-27632 (Selleckchem, Houston, TX, S1049) for 24 hours. iPSCs were then 
differentiated through definitive endoderm, anterior foregut endoderm and lung-specific endoderm stages (Firth 
et al., 2014). All media compositions used for the differentiation are the same as in the original protocol. For 
some experiments, small molecule γ-secretase inhibitors DAPT (Cayman Chemical, Ann Arbor, Michigan, 
208255-80-5) or dibenzazepine (DBZ, Cayman Chemical, Ann Arbor, Michigan, 209984-56-5) were added at 
concentrations of 1, 10 and 20 µM (for DAPT) or 0.5, 2 and 5 µM (for DBZ), starting at Day 17 of differentiation 
until the experimental end point, with media changes every other day.  
 
Immunocytochemistry: Cells were fixed in 3.2% (vol/vol) paraformaldehyde (PFA) for 1 hour at 4°C, washed 3X 
with phosphate-buffered saline (PBS), and permeabilized in 0.5% Triton X-100 for 1 hour at 4oC. Cells were 
blocked for 1 hour with commercial CAS block (Thermo Fisher Scientific, 008120) and then incubated in primary 
antibody (Supplemental Table S2) at 4°C overnight. Cells were washed 3X in 0.1% Triton X-100 in PBS and 
incubated for 1 hour in secondary antibodies. Stained cells were then incubated with DAPI for 5 min before 
washing and mounting on glass microscope slides in Immunomount (Thermo Fisher Scientific, 9990402). 
Alternately, cells were washed after secondary antibody incubation and directly mounted on the glass 
microscope slide using Vectashield with DAPI (Vector Laboratories, Burlingame, CA, H-1500). Images were 
captured at either 20X, 40X or 63X on a Zeiss LSM 800 confocal microscope at the USC Optical Imaging Facility 
(Los Angeles, CA) and processed/counted using Image J (Schneider et al., 2012). 
 
Immunohistochemistry: Explanted human lung tissues were obtained in compliance with an Institutional Review 
Board approved protocol (HS-18-00273) for using human source material in research and the research was 
considered exempt. Tissues were fixed for 24 hours in formalin, embedded in paraffin and sectioned at 10 µm 
thickness. Paraffin-embedded sections were deparaffinized by washing 3 x 4 min in 100% toluene, 1 x 3 min in 
95% EtOH (vol/vol), 1x 3 min in 70% EtOH (vol/vol), 1 x 3 min in 50% EtOH (vol/vol) and finally with distilled 
water.  Antigen retrieval buffer (Sigma) was pre-heated to 95°C, and slides were incubated for 30 min and 
allowed to cool for 20 min at room temperature. Slides were blocked in CAS block for a minimum of 1 hour before 
staining in primary antibody (Supplemental Table S2) overnight at 4°C. Sections were washed 3x in 0.1% Triton 
X-100 in PBS and incubated for 1 hour in secondary antibody. Slides were mounted using Vectashield with DAPI 
(Vector Laboratories). Images were captured at 20X, 40X or 63X on a Zeiss LSM 800 confocal microscope at 
the USC Optical Imaging Facility.  
 
Quantitative RT-PCR: Total RNA was isolated using the Qiagen RNA Easy Mini Kit (74004, 74134) as per the 
manufacturer’s protocol. Then, 500 ng of RNA was DNase-treated (Worthington Biochemical Corporation, 
Lakewood, NJ, LS003172) per the manufacturer’s protocol and reverse-transcribed to cDNA using a Protoscript 
first strand synthesis kit (New England Biolabs, E6560S). Quantitative PCR was performed using SYBR Green 
(Biorad, 1725125) in a 5 μl reaction volume at 50 °C for 2 min, 95 °C for 10 min, 95 °C for 15 s, and 60 °C for 1 
min for 40 cycles and analyzed using 7900HT SDS software (Biorad). Each run consisted of triplicate technical 
repeats per experiment. Beta-actin was used as an internal control. The data were normalized to Day 0 for Fig 
3D to observe the overall increase/decrease in key PNEC marker expression over 90 days of differentiation. For 
Supplemental Fig S1D-G, the data were normalized to Day 5 in order to compare the expression of individual 
markers with an earlier time point during differentiation rather than starting iPSCs at Day 0. Since Day 0 iPSCs 
tend to have some expression of some of these markers it makes it harder to track smaller gene expression 
changes over first 30 days of differentiation. Data are expressed as normalized cycle threshold (Ct) ± SEM. 
Primers used for qRT-PCR are included in Supplemental Table S3. 
 
Single cell RNA sequencing: Day 91 differentiation cultures were dissociated for 30 mins at 37oC using Accutase 
to obtain single-cell suspensions. Cells were stained with DAPI and sorted for live single cells followed by cDNA 
library preparation per the Chromium Single-Cell 30 Library Kit (10x Genomics) manufacturer’s guide at the 
Genomics Core of the Department of Biomedical Sciences at Cedars-Sinai Medical Center and sequenced using 
the 10X Genomics platform on a Next Seq 500. Two experimental replicates of 2113 cells and 2039 cells were 
sequenced at 260-280 million reads per sample. 
 
Single cell RNA-seq data analysis to identify iPNEC-associated genes: Raw reads from the 10X Genomics 
platform were de-multiplexed using barcode processing and then aligned to the human reference genome 
(GRCh 38) using STAR aligner. Mitochondrial genes and low abundance genes were filtered out. Post-
normalization expression counts for each gene were collapsed and normalized to unique molecular identifiers 
(UMI) to generate an expression matrix. The count data were analyzed based on the methodology reported by 
Lun et al. (Lun et al., 2016).  A total of 1705 and 1502 cells were selected respectively from each replicate post 
quality control filtering for further analysis. Based on the log transformed counts, a total of 1171 differentially 
expressed (DE) genes were identified to be common between both replicates within the iPNEC cluster in 
comparison to other clusters (Kolodziejczyk et al., 2015). All further analyses were done using this selection of 
1171 DE genes. Graph-based clustering followed by statistical ANOVA test was used to identify biomarkers of 
each cluster. The clustered data was visualized using t-SNE and PCA plots. The PNEC clusters were identified 
by using a gene set enrichment analysis with various human tissues and cells as reference using the K- nearest 
neighbor algorithm (R-package Weighted k-Nearest Neighbors for Classification).  
 
Pseudotemporal reconstruction of differentiation trajectories: Cell fate decisions and differentiation trajectories 
were reconstructed with the single-cell trajectories reconstruction, exploration and mapping v4.1 (H. Chen et al., 
2019). It incorporates a Modified Local Linear Embedding (MLLE) along with ElPiGraph (Lever et al., 2016; 
Zhang and Wang, 2006) and is not dependent on the predefined number of branches thereby allowing an 
unbiased study of lineage potential across a heterogeneous population (Qiu et al., 2017). To define the 
developmental trajectories, we used cluster-based MST (minimum spanning tree) analysis to infer the lineage 
structure.  We used normalized expression values to generate a pseudotime plot that can account for both 
branched and linear differentiation processes. We have further analyzed the potential marker genes associated 
with each trajectory and its branching.  Additionally, we have used the Monocle package that uses reverse graph 
embedding to reconstruct lineage trajectories (Trapnell, 2020; Trapnell et al., 2014a, 2014b). We selected cells, 
that were projected onto specific lineages based on the branches termed as cell ‘‘states”.  Subsequently, we 
reran the Monocle3 algorithm and assigned basal cells as starting cell lineage until only a single/ simple trajectory 
was identified.   
 
Enzyme-linked immunosorbent assay (ELISA): ELISA was performed using Human Enolase 2/Neuron-specific 
Enolase Quantikine ELISA Kit (R&D systems), as per the manufacturer’s instructions. The experiment was 
repeated four times with basal media and iPSC-conditioned media as controls.  
 
Differentiation of HTEC: Human donor lung specimens were dissected into smaller segments for dissociating 
and harvesting the airway cells (Gu et al., 2014). Total epithelial cell yield will vary depending upon tissue viability 
and size. Airway epithelial cells were seeded on to collagen IV-coated transwell membranes. A collagen stock 
(Corning, 3470) of 60 µg/mL was used as the working solution for coating membrane surfaces. The day after 
seeding the media was removed from the apical surface (air-interfacing) and from there on the cultures were 
maintained under air-liquid-interface (ALI) conditions. The experiment was repeated with HTEC preparations 
from seven different donor lungs. 
 
Image analysis: Images captured on an LSM 800 confocal microscope were quantified and analyzed using 
ImageJ (Schneider et al., 2012).  
 
iPNEC quantification: To quantify iPNECs in a given culture, the mean fluorescence intensity of the antibody 
stain and DAPI were quantified for 10-12 images (which covered almost the entire filter) at 20X magnification 
per time point/condition. For all quantifications, unless otherwise mentioned, percentage of MFI was calculated 
for each marker fluorescence relative to total DAPI fluorescence, followed by statistical analysis.  
 
iPNEC branching analysis: To measure the phenotypic complexity of iPNECs, we used the Sholl analysis plugin 
on ImageJ, commonly used for analyzing neuronal arbors (https://imagej.net/Sholl_Analysis), to measure the 
extent of iPNEC intersections. 10-12 images at 20X magnification per time point/condition were used for the 
analysis of each marker. For Sholl analysis, the outputs measured were number of intersections (I) and branching 
density (I/area of analyzed) (Binley et al., 2014; Bird and Cuntz, 2019; “Sholl Analysis,” n.d.; Sholl, 1953; Stanko 
and Fenton, 2017).  
 
Statistical analysis: All experiments were conducted using at least three technical replicates (e.g., three 6-wells 
or Transwells) from the same differentiation. All experiments were performed (independent differentiations) at 
least three times except where otherwise indicated. Unless otherwise noted, all analyses were performed in 
GraphPad Prism v.6. All data are presented as mean ± SEM. Statistical significance was determined by Student’s 
t test (two-tailed) between two groups. Three or more groups were analyzed by one-way analysis of variance 
(ANOVA). P < 0.05 was considered statistically significant.  
 
Accession numbers: Raw scRNAseq data of primary human fetal lung-derived PNECs have been deposited in 
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